The role of elastography in non-alcoholic fatty liver disease

被引：9

作者：

Liguori, Antonio ^{[1
]}

Ainora, Maria E. ^{[1
]}

Riccardi, Laura ^{[1
]}

De Matthaeis, Nicoletta ^{[1
]}

Pizzolante, Fabrizio ^{[1
]}

Gasbarrini, Antonio ^{[1
,2
]}

Zocco, Maria A. ^{[1
,2
]}

Grieco, Antonio ^{[1
,2
]}

Rapaccini, Gianludovico ^{[1
,2
]}

Miele, Luca ^{[1
,2
]}

机构：

[1] Sacred Heart Catholic Univ, IRCCS A Gemelli Univ Polyclin Fdn, Dept Med & Surg Sci, Largo Gemelli 8, I-00168 Rome, Italy

[2] Sacred Heart Catholic Univ, Dept Med & Translat Surg, Rome, Italy

来源：

MINERVA GASTROENTEROLOGY | 2021年 / 67卷 / 02期

关键词：

Non-alcoholic fatty liver disease; Review; Gastroenterology; MAGNETIC-RESONANCE ELASTOGRAPHY; RADIATION FORCE IMPULSE; TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; DIAGNOSTIC-ACCURACY; NONINVASIVE TOOLS; FIBROSIS; METAANALYSIS; PERFORMANCE; MANAGEMENT;

D O I：

10.23736/S2724-5985.21.02801-4

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and its prevalence is even higher in patients with risk factors such as type 2 diabetes and obesity. Liver biopsy is the gold standard for diagnosis of non-alcoholic steatohepatitis (NASH), particularly for the assessment of fibrosis stage that is a key prognostic factor. Noninvasive methods for assessment of liver fibrosis are a huge need in contemporary hepatology in order to stratify patient's risk of advanced and progressive liver disease. In this perspective different imaging techniques have been developed in last decades and showed high performance in liver fibrosis evaluation. Strengths and weaknesses of all imaging methods are summarized in this review.

引用

页码：164 / 170

页数：7

共 50 条

[41] Timely diagnosis and staging of non-alcoholic fatty liver disease using transient elastography and clinical parameters
Shieh, Christine
Halegoua-De Marzio, Dina L.
Hung, Matthew L.
Fenkel, Jonathan M.
Herrine, Steven K.
JGH OPEN, 2020, 4 (05): : 1002 - 1006
[42] Role of ezetimibe in non-alcoholic fatty liver disease
Theodosios D Filippatos
Moses S Elisaf
World Journal of Hepatology, 2011, 3 (10) : 265 - 267
[43] The Role of Non-Alcoholic Fatty Liver Disease in Cardiovascular Disease
Perseghin, Gianluca
DIGESTIVE DISEASES, 2010, 28 (01) : 210 - 213
[44] Pathology of non-alcoholic fatty liver disease
Bedossa, Pierre
LIVER INTERNATIONAL, 2017, 37 : 85 - 89
[45] Non-alcoholic fatty liver disease and diabetes
Reyes-Garcia, Rebeca
Rozas-Moreno, Pedro
Julio Llamoza-Torres, Camilo
Mezquita-Raya, Pedro
MEDICINA CLINICA, 2017, 148 (01): : 33 - 38
[46] Treatment of Non-Alcoholic Fatty Liver Disease
Scherer, Antonia
Dufour, Jean-Francois
DIGESTIVE DISEASES, 2016, 34 : 27 - 31
[47] The Role of Non-alcoholic Fatty Liver Disease in Cardiovascular Disease
Francque, Sven M.
EUROPEAN CARDIOLOGY REVIEW, 2014, 9 (01) : 10 - 15
[48] PEDIATRIC NON-ALCOHOLIC FATTY LIVER DISEASE
Delvin, Edgard
Patey, Natasha
Dubois, Josee
Henderson, Melanie
Levy, Emile
JOURNAL OF MEDICAL BIOCHEMISTRY, 2015, 34 (01) : 3 - 12
[49] Non-alcoholic fatty liver disease (NAFLD)
Rau, Monika
Weiss, Johannes
Geier, Andreas
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (14) : 1051 - +
[50] Noninvasive imaging assessment of non-alcoholic fatty liver disease: focus on liver scintigraphy
Tovo, Cristiane Valle
de Mattos, Angelo Zambam
Coral, Gabriela Perdomo
Branco, Fernanda Schild
Suwa, Eiji
de Mattos, Angelo Alves
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (15) : 4432 - 4439

← 1 2 3 4 5 →